This article is more than 5 years old. Information may no longer be current.
OSSIO announces US launch and first commercial use of its bone pin for hammertoe correction
Click Here to Manage Email Alerts
OSSIO Inc. announced the U.S. launch and first commercial use of its OSSIOfiber bone pin family for bone fractures, osteotomies, arthrodesis and bone grafts.
According to a company press release, the first hammertoe repair cases with the pin were performed at the Polaris Surgery Center in Westerville, Ohio. The OSSIOfiber bone pin family received FDA 510(k) clearance in January and was intended to be used for treatment of forefoot conditions in which removal surgeries are prevalent. The OSSIOfiber intelligent bone regeneration technology uses bio-integrative material, which reportedly offers stability and secure bone fixation during healing and leaves no permanent hardware.
OSSIO plans to use the OSSIOfiber for additional procedures and will launch in limited markets in the next few weeks. In the third quarter of 2019, the company anticipates making the platform available in all states.
“The U.S. market anticipation for OSSIOfiber has been overwhelmingly positive to date,” Brian Verrier, CEO of OSSIO, said in the release. “We are poised to initiate broader U.S. commercialization of the implant system in the coming weeks, offering surgeons and their patients a new standard of care in orthopedic fixation.”
Re ference :